It updates global disability estimates for the first time in 40 years and finds that 20% of the world's poorest people have disabilities and nearly 80% of people with disabilities live in low-income countries.
Prostate cancer is a key driver of cancer-related global disability-adjusted life-years.
The concept of global disability implicitly encompasses all the PSDs a person may experience in relation to migraine.
Bipolar disorders are ranked amongst the top ten causes of global disability and cause high health care costs.
Medication-overuse headache (MOH), with an adult mean global prevalence of 1.5 2% [7], also contributes substantially to global disability [2, 3].
By one estimate, as much as 45% of global deaths and 35% of global disability-adjusted life years could be addressed through high-quality emergency care [3].
A few variables were identified as associated with a handful of PSDs, namely global disability, emotional problems, pain and headaches frequency.
Evidence exists that pharmacological treatments have an impact toward improvement in patients' difficulties, in particular emotional problems, physical and mental health, difficulties with employment and global disability.
On the contrary, there is more evidence that migraine-specific treatments improve emotional problems, physical and mental health, difficulties with employment and global disability.
